Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 7, 2012; 18(41): 5948-5956
Published online Nov 7, 2012. doi: 10.3748/wjg.v18.i41.5948
Published online Nov 7, 2012. doi: 10.3748/wjg.v18.i41.5948
Total patients (n = 74) | Symptom improvement (n = 52) | Symptom resistance (n = 22) | ||||
Male:female (n) | 26:48 | 18:34 | 8:14 | |||
Age (range), yr | 51.7 (19-70) | 53.5 (27-70) | 47.6 (19-70) | |||
Height | 165.2 ± 12.4 | 166.3 ± 11.6 | 164.9 ± 10.1 | |||
Weight | 61.3 ± 9.7 | 62.3 ± 9.1 | 58.8 ± 10.2 | |||
Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | |
Symptom severity score | 8.09 ± 0.43 | 5.51 ± 0.46a | 8.90 ± 0.46 | 4.52 ± 0.47a | 6.18 ± 0.85 | 7.86 ± 0.92 |
Symptom frequency score | 9.27 ± 0.49 | 6.81 ± 0.54a | 9.96 ± 0.54 | 5.79 ± 0.60a | 7.64 ± 1.01 | 9.23 ± 0.97 |
Gastric dysrhythmia (pre-prandial) | ||||||
Bradygastria | 16 (21.6) | 11 (14.9) | 9 (17.3) | 7 (13.5) | 6 (27.3) | 4 (18.2) |
Normogastria | 33 (44.6) | 52 (70.3)a | 26 (50.0) | 37 (71.2)a | 9 (40.9) | 15 (68.2) |
Tachygastria | 25 (33.8) | 11 (14.9)a | 17 (32.7) | 8 (15.4)a | 7 (31.8) | 3 (13.6) |
Gastric dysrhythmia (post-prandial) | ||||||
Bradygastria | 17 (23.0) | 10 (13.5) | 10 (19.2) | 6 (11.5) | 4 (18.2) | 4 (18.2) |
Normogastria | 33 (44.6) | 45 (60.8) | 26 (50.0) | 37 (71.2)a | 11 (50) | 13 (59.1) |
Tachygastria | 24 (32.4) | 19 (25.7) | 16 (30.8) | 14 (26.9) | 7 (31.8) | 5 (22.7) |
Itopide (n = 24) | Mosapride (n = 28) | Levosulpiride (n = 22) | ||||
Male:female (n) | 5:19 | 10:18 | 11:11 | |||
Age (range), yr | 49.8 (30-64) | 49.6 (19-70) | 56.6 (39-70) | |||
Height | 166.1 ± 10.1 | 163.0 ± 11.0 | 167.1 ± 13.2 | |||
Weight | 60.8 ± 7.7 | 62.7 ± 11.5 | 61.3 ± 10.5 | |||
Symptom improvement | 18 (75) | 17 (61) | 17 (77) | |||
Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | |
Symptom severity score | 7.96 ± 0.84 | 5.00 ± 0.86a | 7.61 ± 0.64 | 5.46 ± 0.79a | 8.86 ± 0.76 | 6.14 ± 0.76a |
Symptom frequency score | 9.21 ± 0.92 | 6.08 ± 0.99a | 8.86 ± 0.78 | 6.86 ± 0.89 | 9.86 ± 0.83 | 7.55 ± 0.96 |
Gastric dysrhythmia (pre-prandial) | ||||||
Bradygastri | 5 (20.8) | 4 (16.7) | 6 (21.4) | 4 (14.3) | 4 (18.2) | 3 (13.6) |
Normogastria | 8 (33.3) | 17 (70.8)a | 15 (53.6) | 18 (64.3) | 12 (54.5) | 15 (68.2) |
Tachygastria | 11 (45.8) | 3 (12.6)a | 7 (25) | 6 (21.4) | 6 (27.3) | 4 (18.2 |
Gastric dysrhythmia (post-prandial) | ||||||
Bradygastria | 5 (20.8) | 3 (12.5) | 6 (21.4) | 6 (21.4) | 3 (13.6) | 1 (4.5) |
Normogastria | 11 (45.8) | 14 (58.3) | 12 (42.9) | 16 (57.1) | 14 (63.6) | 15 (68.2) |
Tachygastria | 8 (33.3) | 7 (29.2) | 10 (35.7) | 6 (21.4) | 5 (22.7) | 6 (27.3) |
- Citation: Lim HC, Lee SI, Chen JD, Park H. Electrogastrography associated with symptomatic changes after prokinetic drug treatment for functional dyspepsia. World J Gastroenterol 2012; 18(41): 5948-5956
- URL: https://www.wjgnet.com/1007-9327/full/v18/i41/5948.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i41.5948